Qiming Venture Partners Exclusively Leads Makera's Pre-A Round

Makera is a pioneer in consumer-grade desktop CNC (Computer Numerical Control) technology

Makera, a pioneer in consumer-grade desktop CNC (Computer Numerical Control) technology, announced the completion of its Pre-A financing round, raising tens of millions of RMB in an exclusive deal led by Qiming Venture Partners.

The new capital will fuel R&D of core technologies, manufacturing expansion, and global branding, accelerating Makera's mission to make precision desktop CNC tools accessible to makers, small businesses, and educators worldwide. The funding also underscores growing investor confidence in the emerging consumer desktop CNC segment for makers and DIY users.

01/

Maker DNA at the Core

Founded in 2019 by a team of passionate makers, Makera develops intelligent, easy-to-use precision CNC machines that deliver industrial-grade performance in a compact, affordable form.

CEO and Founder Josh Zhang brings over a decade of experience in software, product design, and entrepreneurship across the U.S. and China. Frustrated by traditional CNC machines—often expensive, complex, and bulky—Josh Zhang set out to "democratize CNC technology," empowering users of all skill levels to turn their ideas into high-quality creations.

02/

From Flagship Products to a Complete Ecosystem

Makera's flagship products, Carvera and Carvera Air, rank among the top two most-funded CNC projects in Kickstarter history, cementing the company's reputation for precision, versatility, and user-friendliness.

Building on this success, Makera will introduce the Makera Z1 in Q4 2025—a thousand-dollar-level desktop CNC that delivers professional-grade performance at an entry-level price. Alongside Makera Z1, the company will launch Makera Studio, an intelligent CAM toolpath-generation platform, and Makerables, a global content and learning community for makers.

Together, these form Makera's integrated "hardware + software + content" ecosystem, designed to make desktop CNC as intuitive and accessible as 3D printing.

03/

Technology-Driven Competitive Edge

Makera's Carvera system integrates automatic and rapid tool changing, auto-leveling, dust collection, and rotary machining in a single compact unit. It is the first desktop CNC to incorporate an industrial-grade closed-loop control system, achieving 0.01 mm accuracy—a level of precision that surpasses most consumer devices.

Complementing the hardware, Makera Studio—developed in-house over three years—offers intuitive workflow guidance, tutorials, and one-click toolpath generation, dramatically reducing the CNC learning curve and enabling both professionals and beginners to create with confidence.

"This funding marks a pivotal step as Makera transitions from technological innovation to ecosystem expansion," said Josh Zhang, Founder and CEO of Makera. "We believe desktop CNC is approaching its iPhone moment—a plug-and-play smart terminal that belongs on every creator's desk. Our goal is to make precision manufacturing as simple and inspiring as 3D printing."

"Makera is the first desktop CNC brand to make 'lowering user barriers' its central mission," said Kuantai Yeh, Partner at Qiming Venture Partners. "With its innovative hardware, proprietary CAM software, and the upcoming entry-level Makera Z1 and AIGC-powered Makerables community, Makera is poised to bring precision CNC to millions of homes and studios worldwide."


启明星 | 启明创投独家领投造物时代Pre-A轮融资,开启精密数控工具大众化新纪元

启明观点 | 启明创投叶冠泰:影石创新十年磨一剑,"影像+AI技术"的想象空间巨大

启明荣誉 | 启明创投入选最科技T50——中国先锋科技投资机构50强榜单


启明创投成立于2006年。目前,启明创投旗下管理11只美元基金,7只人民币基金,已募管理资产总额达到95亿美元。自成立至今,专注于投资科技(Technology)、医疗创新(Healthcare)等行业早期和成长期的优秀企业。

截至目前,启明创投已投资超过580家高速成长的创新企业,其中有超过210家分别在美国纽交所、纳斯达克,香港交易所,上交所及深交所等交易所上市,或通过并购等方式退出,有80多家企业成为行业公认的独角兽或超级独角兽企业。

启明创投投资企业中,很多已经成长为各自领域中最具影响力的公司,包括小米集团(01810.HK)、美团(03690.HK)、哔哩哔哩(NASDAQ:BILI, 09626.HK)、知乎(NYSE:ZH, 02390.HK)、石头科技(688169.SH)、优必选(09880.HK)、文远知行(NASDAQ:WRD)、海博思创(688411.SH)、影石创新(688775.SH)、云知声(09678.HK)、甘李药业(603087.SH)、泰格医药(300347.SZ, 03347.HK)、再鼎医药(NASDAQ:ZLAB, 09688.HK)、康希诺生物(688185.SH, 06185.HK)、Schrödinger(NASDAQ:SDGR)、惠泰医疗(688617.SH)、三友医疗(688085.SH)、艾德生物(300685.SZ)、贝瑞基因(000710.SZ)、神州细胞(688520.SH)、圆心科技、英矽智能、宜联生物、礼新医药、智谱、阶跃星辰、壁仞科技等。